Newsletter
Continuous Glucose Monitoring in T1DM, Ticragelor vs DAPT in ACS, Nasal ACE2 Levels and COVID-19 in Children, and more

JAMA Editor’s Summary

Continuous Glucose Monitoring in T1DM, Ticragelor vs DAPT in ACS, Nasal ACE2 Levels and COVID-19 in Children, and more

Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the
June 16, 2020
ADVERTISEMENT

Newer →

COVID-19 Vaccines and Therapeutics, Clinical Genomics in Critically Ill Children, and more

← Older

COPD and Dysanapsis, Migraine Aura and CVD, Prone Positioning for COVID19, and more
Buffer LinkedIn WhatsApp

Continuous Glucose Monitoring in T1DM, Ticragelor vs DAPT in ACS, Nasal ACE2 Levels and COVID-19 in Children, and more

Editor’s Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the June 16, 2020 issue

ADVERTISEMENT
ADVERTISEMENT

Listen on your favorite player

New to Podcasts? It's easy to get started!

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Join Our Newsletter

We gratefully acknowledge the many organizations that have generously supported our podcasts and platform.

Silver Sponsors

Bronze Sponsors

Event and Media Partners

Buffer LinkedIn WhatsApp
00:00
00:00